About Conference
Conference Series is delighted to welcome participants from across the globe to the “13th World Kidney Congress” (Kidney Meet 2027), scheduled to take place on June 22–23, 2027, in London, UK, under the theme “Emerging Therapies and Advanced Technologies in Nephrology”.
Kidney Meet 2027 will serve as a prestigious international platform, bringing together leading nephrologists, renowned experts, researchers, clinicians, academicians, and industry professionals to exchange knowledge and discuss the latest advancements in nephrology. The congress will highlight ground breaking research, emerging technologies, innovative diagnostic approaches, and advanced treatment strategies for kidney-related disorders.
This global gathering will provide an excellent opportunity to connect with distinguished professionals, establish valuable collaborations, explore the latest scientific developments, and participate in insightful discussions that contribute to the advancement of kidney healthcare.
The scientific program will feature keynote lectures, plenary sessions, oral and poster presentations, interactive workshops, and industry exhibitions, offering participants a comprehensive platform for scientific learning and professional engagement.
Furthermore, the congress is dedicated to encouraging and supporting emerging talent through its Poster Award Competition and Young Researchers Forum, providing early-career researchers and young professionals with valuable opportunities to showcase their research, gain recognition, and contribute to the future of nephrology.
Why Attend Kidney Meet 2027?
Kidney Meet 2027 aims to bridge the gap between scientific research, clinical practice, and technological innovation to address kidney-related diseases, advance healthcare, and improve patient outcomes. The congress will provide participants with valuable insights into diverse research methodologies, evidence-based clinical case studies, and integrated treatment approaches for both acute and chronic kidney disorders.
This international congress offers an excellent opportunity to:
-
Exchange knowledge and innovative ideas with leading nephrologists and distinguished experts from around the world.
-
Explore the latest advancements in diagnostic techniques, therapeutic interventions, and preventive strategies for kidney diseases.
-
Foster multidisciplinary collaborations to advance research, clinical practice, and comprehensive kidney care.
-
Build meaningful professional connections with clinicians, academicians, researchers, healthcare professionals, and industry experts.
Target Audience:
-
Nephrologists & Kidney Specialists
-
General Physicians & Renal Practitioners
-
Urology & Nephrology Professors
-
Renal Transplantation Surgeons
-
Postdoctoral Researchers & Academicians
-
Renal Dietitians & Nutrition Experts
-
Young Research Scientists & Students
-
Medical and Pharmaceutical Companies
-
Laboratory Technicians & Diagnostic Experts
-
Business Delegates & Entrepreneurs
-
Nephrology and Urology Associations & Societies
Sessions & Tracks
Track 1: Chronic Kidney Disease
Chronic Kidney Disease (CKD) is a progressive medical condition characterized by the gradual loss of kidney function, potentially leading to serious health complications if left unmanaged. It is strongly associated with underlying conditions such as diabetes and hypertension and may remain asymptomatic during its early stages, resulting in delayed diagnosis. Early detection, regular screening, and appropriate lifestyle modifications play a crucial role in slowing disease progression. Effective management involves a comprehensive approach, including dietary modifications, appropriate pharmacological treatment, blood pressure and blood glucose control, and preventive healthcare strategies to preserve kidney function and improve patients' quality of life.
Key Topics: Diabetes-related CKD | Hypertension-induced CKD
Track 2: Cardiovascular Impact of Kidney Disease
Chronic Kidney Disease (CKD) is associated with a significantly increased risk of cardiovascular complications, including heart disease, stroke, and premature mortality. Even mild impairment of kidney function can contribute to cardiovascular risk, highlighting the close relationship between renal and cardiovascular health. Patients with advanced CKD, particularly those undergoing dialysis, are especially vulnerable to cardiovascular events and related complications. Therefore, integrating preventive cardiology, early risk assessment, and comprehensive cardiovascular management into nephrology practice is essential to improve patient outcomes and reduce disease-related mortality.
Key Topics: Heart Failure in CKD | Dialysis-Related Cardiac Risks
Track 3: Kidney Transplantation
Kidney transplantation is widely recognized as the preferred treatment for eligible patients with end-stage kidney disease, offering improved survival rates and quality of life compared with long-term dialysis. Advancements in surgical techniques, organ preservation methods, and immunosuppressive therapies have significantly enhanced transplant outcomes. However, long-term graft survival depends on several factors, including donor-recipient compatibility, effective immunological management, and comprehensive post-transplant care. Ongoing research continues to focus on improving immune tolerance, minimizing graft rejection, and developing innovative strategies to enhance long-term transplant success.
Key Topics: Living Donor Transplantation | Immunosuppressive Therapy
Track 4: Hypertension and Kidney Health
Hypertension plays a significant role in the development and progression of kidney disease, acting as both a contributing factor and a consequence of impaired renal function. Persistently elevated blood pressure can progressively damage the renal blood vessels and tissues, accelerating kidney function deterioration and increasing the risk of Chronic Kidney Disease (CKD). It is also closely associated with renal complications, including hypertensive nephropathy and vascular kidney disorders. Early diagnosis, regular blood pressure monitoring, and appropriate therapeutic interventions are essential to minimize renal damage, slow disease progression, and preserve long-term kidney function.
Key Topics: Hypertensive Nephropathy | Renal Vascular Disease
Track 5: Pharmacological Approaches in Kidney Disease
Pharmacological interventions play a crucial role in the management of Chronic Kidney Disease (CKD) and its associated complications. Advances in immunotherapy, targeted drug development, and personalized treatment approaches are contributing to improved therapeutic outcomes and enhanced patient care. Ongoing research also explores the potential integration of traditional and complementary therapies with evidence-based modern medical practices. Particular attention must be given to medication safety, appropriate dosage adjustments, drug interactions, and renal function monitoring to minimize adverse effects and ensure effective treatment in patients with impaired kidney function.
Key Topics: Immunotherapy in Nephrology | Drug Toxicity in CKD
Track 6: Kidney Failure
Kidney failure is a serious medical condition characterized by the significant impairment or complete loss of the kidneys' ability to filter waste products and excess fluids from the blood. This can result in the accumulation of harmful substances, fluid and electrolyte imbalances, and severe systemic complications affecting multiple organs. Depending on the severity and stage of the condition, treatment options may include medical management, dialysis, or kidney transplantation, which are essential interventions for patients with advanced kidney failure. Early diagnosis, timely intervention, and appropriate clinical management are crucial to slowing disease progression, preserving residual kidney function, and preventing life-threatening complications.
Key Topics: Acute Renal Failure | End-Stage Renal Disease
Track 7: Kidney Stones
Kidney stones are hard, crystalline deposits formed from minerals and salts that accumulate within the kidneys and may obstruct the urinary tract, causing significant discomfort and complications. Common risk factors include inadequate fluid intake, obesity, dietary imbalances, and certain metabolic disorders. Clinical symptoms may range from severe flank or abdominal pain and painful urination to nausea, vomiting, and blood in the urine (hematuria). Treatment approaches depend on the size, location, and composition of the stones and may include increased fluid intake, medication, minimally invasive procedures, or surgical intervention. Early diagnosis, appropriate treatment, and preventive lifestyle modifications are essential to reduce complications and minimize the risk of recurrence.
Key Topics: Stone Prevention Strategies | Surgical Stone Management
Track 8: Critical Care Nephrology
Critical Care Nephrology focuses on the diagnosis and management of acute kidney complications and renal dysfunction in critically ill patients, particularly those admitted to intensive care units (ICUs). It plays a vital role in managing patients with acute kidney injury, severe electrolyte imbalances, fluid overload, and multi-organ dysfunction. Renal replacement therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy (CRRT), are essential in supporting kidney function and maintaining physiological stability in critically ill patients. Ongoing advancements in dialysis technologies, treatment protocols, and critical care interventions are contributing to improved clinical outcomes, enhanced patient management, and increased survival rates in complex cases.
Key Topics: Acute Kidney Injury in ICU | Dialysis Modalities in Critical Care
Track 9: Pediatric and Geriatric Nephrology
Pediatric and Geriatric Nephrology address the distinct challenges associated with kidney health across different stages of life. Pediatric nephrology focuses on the diagnosis, treatment, and management of congenital kidney abnormalities, inherited renal disorders, and other kidney-related conditions affecting children. In contrast, geriatric nephrology addresses age-related changes in kidney function, Chronic Kidney Disease (CKD), and associated comorbidities, which are often diagnosed at advanced stages in older adults. A personalized and multidisciplinary approach to care, supported by early diagnosis, appropriate treatment strategies, and continuous monitoring, is essential to improving clinical outcomes, preserving kidney function, enhancing long-term survival, and promoting a better quality of life for both pediatric and elderly patients.
Key Topics: Polycystic Kidney Disease in Children | CKD in Elderly Patients
Track 10: Women’s Health and Pregnancy
Pregnancy places increased physiological demands on kidney function, particularly in women with pre-existing renal conditions or other high-risk factors. Chronic kidney disease and other underlying renal disorders can significantly increase the risk of pregnancy-related complications, including preeclampsia, hypertension, and impaired fetal development. Comprehensive maternal and fetal monitoring, regular assessment of renal function, and timely clinical interventions are essential to ensuring the well-being of both mother and baby. A specialized multidisciplinary approach involving nephrologists, obstetricians, and maternal-fetal medicine specialists plays a crucial role in managing pregnancy-related renal complications and improving maternal and neonatal outcomes.
Key Topics: Preeclampsia & Kidney Health | Renal Disease in Pregnancy
Track 11: Renal Pathology and Immunology
Renal Pathology focuses on the investigation of structural, cellular, and immunological abnormalities associated with kidney diseases. Kidney biopsies play a vital role in the diagnosis, classification, and assessment of various renal disorders, providing valuable insights into disease progression and guiding appropriate treatment strategies. Advanced diagnostic techniques, including light microscopy, immunofluorescence, and electron microscopy, enable detailed examination of renal tissue and help identify complex pathological changes. Furthermore, ongoing research in renal immunology and molecular pathology is contributing to a deeper understanding of disease mechanisms and paving the way for the development of targeted therapies and personalized treatment approaches.
Key Topics: Kidney Biopsy Techniques | Autoimmune Renal Diseases
Track 12: Mineral and Bone Disorders in CKD
Chronic Kidney Disease (CKD) significantly affects mineral and bone metabolism by disrupting the regulation of calcium, phosphorus, and vitamin D levels. These metabolic disturbances can contribute to Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD), increasing the risk of bone loss, osteoporosis, skeletal deformities, and fractures. Patients with advanced CKD, particularly those undergoing dialysis, require specialized monitoring and individualized management of mineral and bone metabolism to maintain skeletal health. Early diagnosis, regular biochemical assessments, appropriate nutritional interventions, and targeted pharmacological treatments are essential to prevent bone-related complications and improve patients' overall quality of life.
Key Topics: Renal Osteodystrophy | Calcium-Phosphorus Imbalance
Track 13: Diabetic Nephropathy
Diabetic Nephropathy, also known as Diabetic Kidney Disease, is one of the leading causes of Chronic Kidney Disease (CKD) worldwide. It develops as a result of prolonged elevated blood glucose levels, which progressively damage the kidneys' filtering units (glomeruli), impairing their ability to function effectively. Proteinuria, characterized by the presence of excess protein in the urine, is an important early indicator of kidney damage and may signal the onset of renal complications. Early screening, effective blood glucose management, regular monitoring of kidney function, and appropriate lifestyle modifications are essential to slowing disease progression, preventing further renal damage, and reducing the risk of kidney failure.
Key Topics: Proteinuria in Diabetes | Renoprotective Therapies
Track 14: Urology
Urology plays a vital role in the diagnosis, treatment, and management of disorders affecting the urinary tract, bladder, prostate, and associated renal structures. Common urological conditions, including urinary tract infections (UTIs), urinary obstructions, and prostate-related disorders, can significantly impact kidney function if left untreated. Early diagnosis, timely medical intervention, and appropriate clinical management are essential to preventing complications and minimizing the risk of permanent renal damage. Furthermore, advancements in minimally invasive surgical techniques, endoscopic procedures, and innovative treatment technologies are enhancing therapeutic precision, improving patient recovery, and contributing to better clinical outcomes and overall quality of life.
Key Topics: Urinary Tract Infections | Prostate-related Kidney Disorders
Track 15: Nephrology Nursing
Nephrology nursing plays an essential role in the comprehensive care and management of patients with kidney-related disorders, including Chronic Kidney Disease (CKD), dialysis, and kidney transplantation. Specialized nephrology nurses are responsible for patient monitoring, treatment coordination, medication administration, patient education, and the prevention and early identification of potential complications. They serve as a vital link between patients, families, and multidisciplinary healthcare teams, ensuring continuity of care and supporting informed treatment decisions. Advanced clinical training, specialized nursing expertise, and ongoing professional development are crucial to enhancing the quality of renal care, improving patient outcomes, and promoting better long-term health and well-being.
Key Topics: Nursing in Dialysis Care | Patient Education in CKD
Track 16: Renal Nutrition
Nutrition plays a fundamental role in the management of Chronic Kidney Disease (CKD) and in slowing its progression. Appropriate dietary management, including the careful regulation of protein, sodium, potassium, and phosphorus intake, is essential to maintaining nutritional balance and minimizing the risk of complications. Renal nutritionists and dietitians work closely with healthcare professionals to develop individualized dietary plans based on each patient's kidney function, nutritional requirements, and overall health status. Effective nutritional interventions can help manage metabolic imbalances, improve treatment tolerance, support kidney function, and enhance patients' overall health and quality of life.
Key Topics: Dietary Management in CKD | Nutritional Therapy in Dialysis
Track 17: Robotic Kidney Transplantation
Robotic-Assisted Kidney Transplantation (RAKT) represents an innovative advancement in renal surgery, offering a minimally invasive alternative to conventional kidney transplantation. This advanced surgical approach utilizes robotic technology to enhance precision, dexterity, and visualization, potentially reducing surgical trauma, postoperative complications, and recovery time. By enabling greater surgical accuracy and improved procedural control, robotic-assisted techniques are contributing to the evolution of kidney transplantation and patient care. With continued technological advancements and growing clinical experience, RAKT is gaining increasing recognition worldwide as a promising approach in modern transplant surgery.
Key Topics: Robotic-Assisted Surgery | Minimally Invasive Transplantation
Track 18: Dialysis
Dialysis is a life-sustaining renal replacement therapy that helps compensate for impaired kidney function by removing waste products, excess fluids, and toxins from the bloodstream. The two primary modalities are hemodialysis and peritoneal dialysis. Hemodialysis utilizes a specialized dialysis machine and an artificial filter (dialyzer) to cleanse the blood, whereas peritoneal dialysis uses the body's peritoneal membrane as a natural filtering barrier to remove waste and excess fluid. Both approaches play a crucial role in managing advanced kidney disease and maintaining patients' overall health. Ongoing research and technological advancements in dialysis equipment, treatment protocols, and patient care are focused on improving treatment efficiency, enhancing safety, reducing complications, and promoting greater patient comfort and quality of life.
Key Topics: Hemodialysis Techniques | Peritoneal Dialysis
Track 19: Stem Cells in Renal Disorders
Stem cell research represents a promising area of advancement in regenerative medicine, offering new possibilities for kidney tissue repair and regeneration. Mesenchymal stem cells (MSCs) have demonstrated potential protective and immunomodulatory effects in preclinical studies, particularly in addressing inflammation, tissue damage, and mechanisms associated with Chronic Kidney Disease (CKD). Ongoing clinical research and experimental studies are investigating the therapeutic potential of stem cell-based interventions in managing acute and chronic renal injuries. Although further investigation is required to establish their long-term safety and clinical effectiveness, this emerging field holds considerable promise for developing innovative regenerative therapies and advancing the future of kidney disease treatment.
Key Topics: Stem Cell Therapy in CKD | Regenerative Medicine in Nephrology
Track 20: Biomarkers in Kidney Disease
Biomarkers play an increasingly important role in the early detection, diagnosis, and monitoring of kidney diseases, offering valuable insights beyond conventional diagnostic assessments. They help identify renal injury at earlier stages, evaluate disease progression, and assess responses to therapeutic interventions. Emerging biomarkers, including novel molecular, genetic, and urinary indicators, are advancing precision medicine by enabling more individualized approaches to patient care. Their integration into clinical nephrology has the potential to improve diagnostic accuracy, strengthen prognostic assessments, support timely treatment decisions, and enhance the overall management of kidney-related disorders.
Key Topics: Diagnostic Biomarkers | Prognostic Biomarkers
Track 21: Hematology in Kidney Health
Hematological complications are frequently associated with kidney diseases and can significantly affect patients' overall health and clinical outcomes. Anemia is one of the most common complications of Chronic Kidney Disease (CKD), often resulting from reduced erythropoietin production, iron deficiency, and other metabolic disturbances. In addition, abnormalities in blood coagulation and platelet function can increase the risk of bleeding and thrombotic complications in patients with renal disorders. Advanced diagnostic techniques, regular hematological assessments, and targeted therapeutic interventions are essential for the early identification and effective management of these complications, ultimately improving patient outcomes and quality of care.
Key Topics: Anemia in CKD | Coagulation Abnormalities in Nephrology
Market Analysis
Kidney Disease Statistics and Global Outlook
According to current health data, kidney diseases represent the 18th leading cause of mortality in Turkey. The national mortality rate due to kidney disorders is estimated at 5.47 per 100,000, with approximately 2.3 million deaths worldwide annually linked to kidney failure. By 2030, the number of individuals requiring dialysis or transplantation is expected to more than double, exceeding 5 million cases. In Istanbul alone, 1 in every 3 adults is at risk of developing kidney disease, and kidney disorders rank as the 9th leading cause of death. Notably, over 600,000 deaths are attributed to kidney diseases in Istanbul each year.
In Turkey, more than 17,000 kidney transplantations were performed in 2014. Of these, 11,570 were from deceased donors, while 5,535 were from living donors. Despite these efforts, 12 patients die every day while waiting for a transplant, and every 10 minutes a new patient is added to the transplant list. In 2014 alone, 4,270 patients died due to delays in transplantation, and 3,617 became too unwell to undergo the procedure.
The economic burden of kidney disease is significant. Annual treatment costs escalate with disease stage — from $15,000 (Stage 3) to $28,000 (Stage 4), and over $70,000 (Stage 5). In the U.S., Medicare spends approximately $28.6 billion annually on patients with kidney failure, while the overall national expenditure on kidney-related care surpasses $41 billion annually, accounting for 17% of the Medicare budget. The National Kidney Foundation (NKF) has invested over $100 million in kidney research to date.
Globally, the prevalence of Chronic Kidney Disease (CKD) is 14%, with hypertension and diabetes as the primary causes. Nearly 50% of CKD patients also report cardiovascular disease (CVD). In the U.S. alone, over 661,000 individuals live with kidney failure — of these, 468,000 are on dialysis, while 193,000 have functioning kidney transplants. CKD often progresses silently without symptoms in early stages, making it a “silent disease.”
The incidence of End-Stage Renal Disease (ESRD) rose sharply in the 1990s, stabilized in the early 2000s, and has slightly declined since 2006. However, disparities remain: ESRD prevalence is 3.7 times higher in African Americans, 1.4 times higher in Native Americans, and 1.5 times higher in Asian Americans compared to Caucasians.
Societies Associated with Nephrology
Middle East:
Kuwait Nephrology Association, Lebanese Society of Nephrology & Hypertension, Iraqi Society of Nephrology, Saudi Society of Nephrology, Syrian Society of Nephrology & Transplantation, Yemen Society for Nephrology and Transplantation
Asia-Pacific:
Asian Pacific Society of Nephrology, Chinese Society of Nephrology, Hong Kong Society of Nephrology, Japanese Society of Nephrology, Korean Society of Nephrology, Mongolian Society of Nephrology and Urology, Taiwan Society of Nephrology, Australian & New Zealand Society of Nephrology, Cambodian Association of Nephrology, Indonesian Society of Nephrology, Myanmar Nephrology Society, Asian Pacific Society of Hypertension, Turkish Society of Hypertension & Atherosclerosis, High Blood Pressure Research Council of Australia, Indonesian Society of Hypertension
Europe & Africa:
Albanian Society of Nephrology, Israel Society of Nephrology & Hypertension, Bosnian Society of Dialysis & Transplantation, Bulgarian Society of Nephrology, Croatian Society of Nephrology, Estonian Society of Nephrology, Austrian Heart Foundation, British Hypertension Society, European Society of Hypertension, Serbian Association of Cardionephrology, Slovenian Society of Nephrology, Turkish Society of Nephrology, German Society of Nephrology, Swiss Society of Nephrology
Americas:
Argentine Society of Nephrology, Bolivian Society of Nephrology, Brazilian Society of Nephrology, Chilean Society of Nephrology, Colombian Society of Nephrology, Costa Rican Society of Nephrology, Cuban Society of Nephrology, Ecuadorian Society of Nephrology, Salvadoran Association of Nephrology & Hypertension, Guatemalan Society of Nephrology, Mexican College of Nephrologists, Nicaraguan Association of Nephrology, Panamanian Society of Nephrology, Paraguayan Society of Nephrology, Peruvian Society of Nephrology, Puerto Rican Society of Nephrology & Hypertension, Uruguayan Society of Nephrology, Venezuelan Society of Nephrology
Hospitals Associated with Nephrology Research
Europe:
Klinik Im Park (Zurich), Health Centre Bad Ragaz, Klinik Pyramide Am See, Klinik Beau-Site (Berne), Hirslanden Clinique La Colline, Lucerne Health, Salem-Spital (Berne), Hirslanden Klinik Aarau, J.W. Goethe University Hospital
Global:
Mayo Clinic, Cleveland Clinic, New York-Presbyterian Hospital, UCSF Medical Center, Brigham & Women’s Hospital, Johns Hopkins Hospital, Massachusetts General Hospital
Universities Associated with Nephrology Research
Albany Medical College, Boston University School of Medicine, Columbia University, David Geffen School of Medicine (UCLA), Florida State University, Georgetown University, Indiana University, Johns Hopkins University, Loma Linda University, Northeastern Ohio Universities, Ohio State University, Tulane University, University of Maryland, Vanderbilt University, Weill Cornell Medical College, Yale University School of Medicine
Major Nephrology Societies Worldwide
-
International Society of Nephrology (ISN)
-
American Society of Nephrology (ASN)
-
Indian Society of Nephrology (ISN)
-
Canadian Society of Nephrology (CSN)
-
Hong Kong Society of Nephrology (HKSN)
-
The Renal Association (UK)
-
Australian & New Zealand Society of Nephrology (ANZSN)
-
Malaysian Society of Nephrology (MSN)
-
National Kidney Foundation (NKF)
-
Saudi Society of Nephrology & Transplantation (SSN&T)
Past Conference
The 12th World Kidney Congress (KIDNEY MEET 2026) is scheduled to be held on November 16–17, 2026, in Tokyo, Japan, under the theme “Recent Advances and Emerging Future Directions in Nephrology.” The conference aims to bring together nephrologists, kidney specialists, clinicians, researchers, academicians, and healthcare professionals from around the world to share research, exchange scientific knowledge, and explore emerging developments in nephrology and kidney care.
The scientific program will feature keynote lectures, oral and poster presentations, and interactive discussions addressing chronic kidney disease, kidney transplantation, dialysis advancements, glomerular diseases, diabetic nephropathy, renal replacement therapies, and innovative approaches to kidney disease prevention and management. The congress aims to encourage international collaboration, promote research advancements, and provide valuable networking opportunities for participants across the global nephrology community.